Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and Bile Duct Obstruction

levofloxacin has been researched along with Bile Duct Obstruction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S1
Amado, V; Gaio, E; Huang, W; Melo-Silva, CA; Rangel, L; Storck, R1
Kruhlak, NL; Zhu, X1
Levine, C; Perumalswami, PV; Thung, SN; Trivedi, A1

Reviews

1 review(s) available for levofloxacin and Bile Duct Obstruction

ArticleYear
Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
    Seminars in liver disease, 2014, Volume: 34, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Bile Ducts; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Humans; Levofloxacin; Liver Cirrhosis

2014

Other Studies

3 other study(ies) available for levofloxacin and Bile Duct Obstruction

ArticleYear
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors

2012
Levofloxacin decreased chest wall mechanical inhomogeneities and airway and vascular remodeling in rats with induced hepatopulmonary syndrome.
    Respiratory physiology & neurobiology, 2013, Dec-01, Volume: 189, Issue:3

    Topics: Airway Remodeling; Animals; Cholestasis; Disease Models, Animal; Hepatopulmonary Syndrome; Levofloxacin; Lung; Male; Membrane Proteins; Pulmonary Artery; Rats; Rats, Wistar; Respiratory Muscles; Statistics, Nonparametric; Thoracic Wall; Topoisomerase II Inhibitors

2013
Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
    Toxicology, 2014, Jul-03, Volume: 321

    Topics: Algorithms; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Bile Duct Diseases; Calibration; Chemical and Drug Induced Liver Injury; Cholestasis; Data Mining; Databases, Factual; Drug Labeling; Endpoint Determination; Humans; Levofloxacin; Liver; Naproxen; Product Surveillance, Postmarketing; Quantitative Structure-Activity Relationship; Toxicity Tests; Vitamins

2014